Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells

• Tony Navas,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Thomas D. Pfister,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Current address: Tumour Immunotherapy Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

  Affiliation Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Simona Colantonio,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Antibody Characterization Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Amina Aziz,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Biosciences Division, Argonne National Laboratory, Argonne, Illinois, United States of America

  ⨯
• Lynda Dieckman,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Biosciences Division, Argonne National Laboratory, Argonne, Illinois, United States of America

  ⨯
• Richard G. Saul,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Antibody Characterization Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Jan Kaczmarczyk,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Antibody Characterization Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Suzanne Borgel,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Biological Testing Branch, Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, Maryland, United States of America

  ⨯
• Sergio Y. Alcoser,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliation Biological Testing Branch, Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, Maryland, United States of America

  ⨯
• Melinda G. Hollingshead,

  Roles Formal analysis, Supervision, Writing – original draft

  Affiliation Biological Testing Branch, Developmental Therapeutics Program, National Cancer Institute at Frederick, Frederick, Maryland, United States of America

  ⨯
• Young H. Lee,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Donald P. Bottaro,

  Roles Formal analysis, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  http://orcid.org/0000-0002-5057-5334

  ⨯
• Tara Hiltke,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Office of Cancer Clinical Proteomics Research, Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Gordon Whiteley,

  Roles Formal analysis, Project administration, Writing – original draft

  Affiliation Antibody Characterization Laboratory, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  http://orcid.org/0000-0001-7898-6269

  ⨯
• Naoko Takebe,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Robert J. Kinders,

  Roles Conceptualization, Formal analysis, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  http://orcid.org/0000-0002-5310-3367

  ⨯
• Ralph E. Parchment,

  Roles Conceptualization, Formal analysis, Project administration, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Joseph E. Tomaszewski,

  Roles Conceptualization, Formal analysis, Supervision, Writing – original draft

  Affiliation Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• James H. Doroshow

  Roles Conceptualization, Formal analysis, Project administration, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: doroshoj@mail.nih.gov

  Affiliations Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, United States of America, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]